Transfusions with young erythrocytes (neocytes) in sickle cell anemia

Harvey G. Klein

Research output: Contribution to journalArticle

Abstract

Transfusion-induced hemochromatosis is a potential therapeutic complication of the management of sickle cell anemia. Selective transfusion with young erythrocytes (neocyles), which theoretically have a longer life-span than do regular donor red cells, could decrease transfusion frequency and reduce iron deposition in the sickle cell patient. Using blood cell separators, a method has been devised to prepare neocyte units for transfusion. Neocyte enrichment was evaluated by reticulocyte count and mean red cell age was estimated from erythrocyte pyru-vate kinase, an age-dependent enzyme. These neocyte units have an average estimated mean cell age of 30 days compared to 60 days for unfractionated units. Radioch-romium studies in seven splenectomized thalassemia major patients revealed an average half-life of 47.4 days for neocytes stored in the frozen slate compared to an average half-life of 29.5 days for standard frozen red cells. Neocyte aliquots collected from three normal, eusplenic donors had an average estimated mean cell age of 6.5 days and an average half-life of 57.2 days when reinfused. Neocyte units cost $300 to collect and process compared to $92 for frozen red cells, but use of neocyte units could reduce by one-half the transfusion requirement in transfusion-dependent patients.

Original languageEnglish (US)
Pages (from-to)162-165
Number of pages4
JournalAmerican Journal of Pediatric Hematology/Oncology
Volume4
Issue number2
StatePublished - 1982
Externally publishedYes

Fingerprint

Sickle Cell Anemia
Erythrocytes
Half-Life
Tissue Donors
Reticulocyte Count
Pyrus
Hemochromatosis
beta-Thalassemia
Blood Cells
Phosphotransferases
Iron
Costs and Cost Analysis
Enzymes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Pediatrics, Perinatology, and Child Health

Cite this

Transfusions with young erythrocytes (neocytes) in sickle cell anemia. / Klein, Harvey G.

In: American Journal of Pediatric Hematology/Oncology, Vol. 4, No. 2, 1982, p. 162-165.

Research output: Contribution to journalArticle

@article{045fd66a289b4fb4a33b563e74c58f02,
title = "Transfusions with young erythrocytes (neocytes) in sickle cell anemia",
abstract = "Transfusion-induced hemochromatosis is a potential therapeutic complication of the management of sickle cell anemia. Selective transfusion with young erythrocytes (neocyles), which theoretically have a longer life-span than do regular donor red cells, could decrease transfusion frequency and reduce iron deposition in the sickle cell patient. Using blood cell separators, a method has been devised to prepare neocyte units for transfusion. Neocyte enrichment was evaluated by reticulocyte count and mean red cell age was estimated from erythrocyte pyru-vate kinase, an age-dependent enzyme. These neocyte units have an average estimated mean cell age of 30 days compared to 60 days for unfractionated units. Radioch-romium studies in seven splenectomized thalassemia major patients revealed an average half-life of 47.4 days for neocytes stored in the frozen slate compared to an average half-life of 29.5 days for standard frozen red cells. Neocyte aliquots collected from three normal, eusplenic donors had an average estimated mean cell age of 6.5 days and an average half-life of 57.2 days when reinfused. Neocyte units cost $300 to collect and process compared to $92 for frozen red cells, but use of neocyte units could reduce by one-half the transfusion requirement in transfusion-dependent patients.",
author = "Klein, {Harvey G.}",
year = "1982",
language = "English (US)",
volume = "4",
pages = "162--165",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Transfusions with young erythrocytes (neocytes) in sickle cell anemia

AU - Klein, Harvey G.

PY - 1982

Y1 - 1982

N2 - Transfusion-induced hemochromatosis is a potential therapeutic complication of the management of sickle cell anemia. Selective transfusion with young erythrocytes (neocyles), which theoretically have a longer life-span than do regular donor red cells, could decrease transfusion frequency and reduce iron deposition in the sickle cell patient. Using blood cell separators, a method has been devised to prepare neocyte units for transfusion. Neocyte enrichment was evaluated by reticulocyte count and mean red cell age was estimated from erythrocyte pyru-vate kinase, an age-dependent enzyme. These neocyte units have an average estimated mean cell age of 30 days compared to 60 days for unfractionated units. Radioch-romium studies in seven splenectomized thalassemia major patients revealed an average half-life of 47.4 days for neocytes stored in the frozen slate compared to an average half-life of 29.5 days for standard frozen red cells. Neocyte aliquots collected from three normal, eusplenic donors had an average estimated mean cell age of 6.5 days and an average half-life of 57.2 days when reinfused. Neocyte units cost $300 to collect and process compared to $92 for frozen red cells, but use of neocyte units could reduce by one-half the transfusion requirement in transfusion-dependent patients.

AB - Transfusion-induced hemochromatosis is a potential therapeutic complication of the management of sickle cell anemia. Selective transfusion with young erythrocytes (neocyles), which theoretically have a longer life-span than do regular donor red cells, could decrease transfusion frequency and reduce iron deposition in the sickle cell patient. Using blood cell separators, a method has been devised to prepare neocyte units for transfusion. Neocyte enrichment was evaluated by reticulocyte count and mean red cell age was estimated from erythrocyte pyru-vate kinase, an age-dependent enzyme. These neocyte units have an average estimated mean cell age of 30 days compared to 60 days for unfractionated units. Radioch-romium studies in seven splenectomized thalassemia major patients revealed an average half-life of 47.4 days for neocytes stored in the frozen slate compared to an average half-life of 29.5 days for standard frozen red cells. Neocyte aliquots collected from three normal, eusplenic donors had an average estimated mean cell age of 6.5 days and an average half-life of 57.2 days when reinfused. Neocyte units cost $300 to collect and process compared to $92 for frozen red cells, but use of neocyte units could reduce by one-half the transfusion requirement in transfusion-dependent patients.

UR - http://www.scopus.com/inward/record.url?scp=0020320564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020320564&partnerID=8YFLogxK

M3 - Article

C2 - 7114397

AN - SCOPUS:0020320564

VL - 4

SP - 162

EP - 165

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 2

ER -